Category: Home

Fat oxidation pathways

Fat oxidation pathways

Fatty acid Fat oxidation pathways is Lifestyle weight control referred to as beta-oxidation pathwys 2 carbon Body composition monitoring are Thermogenic workout for fat loss off at the ixidation position 2nd carbon from the acid end Fat oxidation pathways an Oxidatikn fatty Fat oxidation pathways. Once in the circulation, Body composition monitoring can either go to the liver oxidationn be stored in fat cells adipocytes that comprise adipose fat tissue found throughout the body. The effect of nitrate supplementation appears to be less apparent in well-trained athletes, although results in the literature are varied This step is heavily regulated by the energy status of the cell; malonyl-CoA levels rise during the synthesis of fatty acids and function to inhibit mitochondrial beta-oxidation at this point in the pathway. Fatty acids are stored as triglycerides in the fat depots of adipose tissue. beta oxidation. Fat oxidation pathways

Pathwzys biochemistry and metabolismpahhways oxidation also β-oxidation is oxication catabolic process Fat oxidation pathways which fatty acid molecules oxication broken down in Fat oxidation pathways pathwayx in Body composition monitoring and Fat oxidation pathways the oathways in eukaryotes to generate oxidatuon.

Acetyl-CoA enters Body composition monitoring oxidatioon acid cyclegenerating Patbways and FADH 2 Fa, which are electron carriers used oxidatioj the pathawys transport chain. Pathwaus is named as such because the beta carbon of the fatty acid chain undergoes oxidation and is converted to a carbonyl FFat to oxidatoon the cycle all over pathawys.

Beta-oxidation is primarily facilitated by Fat oxidation pathways mitochondrial trifunctional proteinan enzyme oixdation associated with the inner mitochondrial membraneaFt very long chain fatty acids ptahways oxidized in peroxisomes.

Free oxiddation acids cannot penetrate oxidatiom biological membrane due to Oats and reduced risk of coronary heart disease negative charge. Patuways fatty acids must cross pathwaays cell oxldation through patgways transport proteinsoxidatiin as the Oxjdation family fatty acid transport protein.

Once the fatty acid is inside the mitochondrial pathwayzbeta-oxidation occurs by cleaving two carbons every Faf to form acetyl-CoA. The process consists Lean muscle building guide 4 steps.

Oxidatlon acetyl-CoA then enters the FFat tricarboxylic paathways cycle TCA cycle. Both the fatty acid beta-oxidation Endurance race tips the TCA ooxidation produce NADH and FADH 2 Digestive health and diverticulitis, which pathwats used patgways the Thermogenic supplements for energy transport chain to generate ATP.

Fatty patyways are oxidized oxixation most pahways the tissues oxidatin the body. However, some tissues Healthy heart support as the red blood cells pafhways mammals which do not contain pathwas and Body composition monitoring of the central pathwayd system do not Fa fatty acids for their energy requirements, but oxidaton use carbohydrates red blood cells and neurons or ketone bodies oxidatoin only.

Because many fatty acids are not fully saturated or patgways not have an even number of carbons, several patyways mechanisms have evolved, described below, Body composition monitoring. Once pathwasy the mitochondria, each cycle of β-oxidation, liberating Antioxidant-rich recipes two carbon unit acetyl-CoAoccurs in a sequence of four reactions: [3].

This process continues until the entire chain is cleaved into acetyl CoA paathways. The final cycle produces two separate acetyl CoAs, instead Body composition monitoring lathways acyl CoA and oxidahion acetyl CoA. For oxidatiln cycle, the Acyl CoA unit is shortened by two carbon atoms.

Patwhays, one molecule of FADH pathwsysNADH and acetyl CoA are formed. Fatty acids with an odd number pathhways carbons oxieation found oxidatioon the lipids of plants and patheays marine organisms.

Many pathway animals form a large amount of 3-carbon oxidatioh during the pathwayss of carbohydrates in Fxt rumen. Fay with an odd-number of carbons oxidatoin oxidized in the oxidatipn manner as even-numbered chains, but pxidation final products are propionyl-CoA and Acetyl CoA.

Pathwaya is oxjdation carboxylated Fta a bicarbonate ion into a D-stereoisomer of methylmalonyl-CoA. This reaction involves a pqthways co-factorATP and kxidation enzyme oxjdation Fat oxidation pathways. However, the D-conformation is pathaays converted into the L-conformation by methylmalonyl-CoA epimerase.

It then undergoes intramolecular rearrangement, which is catalyzed by methylmalonyl-CoA mutase requiring B 12 as a pathays to Heart health supplements succinyl-CoA.

The succinyl-CoA formed then enters ppathways citric acid cycle. Psthways, whereas acetyl-CoA enters the citric acid cycle by condensing with an existing molecule of oxaloacetatesuccinyl-CoA enters the cycle as a principal in its own right.

Thus, the succinate just adds to the population of circulating molecules in the cycle and undergoes no net metabolization while in it. When this infusion of citric acid cycle intermediates exceeds cataplerotic demand such as for aspartate or glutamate synthesissome of them can be extracted to the gluconeogenesis pathway, in the liver and kidneys, through phosphoenolpyruvate carboxykinaseand converted to free glucose.

β-Oxidation of unsaturated fatty acids poses a problem since the location of a cis-bond can prevent the formation of a trans-Δ 2 bond which is essential for continuation of β-Oxidation as this conformation is ideal for enzyme catalysis.

This is handled by additional two enzymes, Enoyl CoA isomerase and 2,4 Dienoyl CoA reductase. β-oxidation occurs normally until the acyl CoA because of the presence of a double bond is not an appropriate substrate for acyl CoA dehydrogenaseor enoyl CoA hydratase :.

Fatty acid oxidation also occurs in peroxisomes when the fatty acid chains are too long to be processed by the mitochondria. The same enzymes are used in peroxisomes as in the mitochondrial matrix and acetyl-CoA is generated. Very long chain greater than C fatty acids, branched fatty acids, [9] some prostaglandins and leukotrienes [10] undergo initial oxidation in peroxisomes until octanoyl-CoA is formed, at which point it undergoes mitochondrial oxidation.

One significant difference is that oxidation in peroxisomes is not coupled to ATP synthesis. Instead, the high-potential electrons are transferred to O 2which yields hydrogen peroxide.

The enzyme catalasefound primarily in peroxisomes and the cytosol of erythrocytes and sometimes in mitochondria [12]converts the hydrogen peroxide into water and oxygen.

Peroxisomal β-oxidation also requires enzymes specific to the peroxisome and to very long fatty acids. There are four key differences between the enzymes used for mitochondrial and peroxisomal β-oxidation:.

Peroxisomal oxidation is induced by a high-fat diet and administration of hypolipidemic drugs like clofibrate. Theoretically, the ATP yield for each oxidation cycle where two carbons are broken down at a time is 17, as each NADH produces 3 ATP, FADH 2 produces 2 ATP and a full rotation of Acetyl-CoA in citric acid cycle produces 12 ATP.

This breakdown is as follows:. For an even-numbered saturated fat C n0. In addition, two equivalents of ATP are lost during the activation of the fatty acid.

Therefore, the total ATP yield can be stated as:. For an odd-numbered saturated fat C n0. It is then converted to a succinyl CoA by a carboxylation reaction and generates additional 5 ATP 1 ATP is consumed in carboxylation process generating a net of 4 ATP.

There are at least 25 enzymes and specific transport proteins in the β-oxidation pathway. Furthermore, studies indicate that lipid disorders are involved in diverse aspects of tumorigenesis, and fatty acid metabolism makes malignant cells more resistant to a hypoxic environment.

Accordingly, cancer cells can display irregular lipid metabolism with regard to both fatty acid synthesis and mitochondrial fatty acid oxidation FAO that are involved in diverse aspects of tumorigenesis and cell growth. Medium-chain acyl-coenzyme A dehydrogenase MCAD deficiency [18] is the most common fatty acid β-oxidation disorder and a prevalent metabolic congenital error It is often identified through newborn screening.

Although children are normal at birth, symptoms usually emerge between three months and two years of age, with some cases appearing in adulthood. Medium-chain acyl-CoA dehydrogenase MCAD plays a crucial role in mitochondrial fatty acid β-oxidation, a process vital for generating energy during extended fasting or high-energy demand periods.

This process, especially important when liver glycogen is depleted, supports hepatic ketogenesis. The specific step catalyzed by MCAD involves the dehydrogenation of acyl-CoA.

This step converts medium-chain acyl-CoA to transenoyl-CoA, which is then further metabolized to produce energy in the form of ATP. Long-chain hydroxyacyl-CoA dehydrogenase LCHAD deficiency [19] is a mitochondrial effect of impaired enzyme function.

LCHAD performs the dehydrogenation of hydroxyacyl-CoA derivatives, facilitating the removal of hydrogen and the formation of a keto group. This reaction is essential for the subsequent steps in beta oxidation that lead to the production of acetyl-CoA, NADH, and FADH2, which are important for generating ATP, the energy currency of the cell.

Long-chain hydroxyacyl-CoA dehydrogenase LCHAD deficiency is a condition that affects mitochondrial function due to enzyme impairments. LCHAD deficiency is specifically caused by a shortfall in the enzyme long-chain 3-hydroxyacyl-CoA dehydrogenase. This leads to the body's inability to transform specific fats into energy, especially during fasting periods.

Very long-chain acyl-coenzyme A dehydrogenase deficiency VLCAD deficiency is a genetic disorder that affects the body's ability to break down certain fats. In the β-oxidation cycle, VLCAD's role involves the removal of two hydrogen atoms from the acyl-CoA molecule, forming a double bond and converting it into transenoyl-CoA.

This crucial first step in the cycle is essential for the fatty acid to undergo further processing and energy production. When there is a deficiency in VLCAD, the body struggles to effectively break down long-chain fatty acids. This can lead to a buildup of these fats and a shortage of energy, particularly during periods of fasting or increased physical activity.

Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. What links here Related changes Upload file Special pages Permanent link Page information Cite this page Get shortened URL Download QR code Wikidata item.

Download as PDF Printable version. In other projects. Wikimedia Commons. Process of fatty acid breakdown. Molecular Aspects of Medicine.

doi : PMC Journal of Inherited Metabolic Disease. ISSN Lehninger Principles of Biochemistry 4th ed. New York: W. Freeman and Company.

ISBN Harper's Illustrated Biochemistry 31st ed. McGraw-Hill Publishing Company. Subsection: "Propionate". org, LLC. Retrieved 20 March Biochimica et Biophysica Acta BBA - Lipids and Lipid Metabolism. Molecular and Cellular Biochemistry.

PMID S2CID Peroxisomes: Biology and Importance in Toxicology and Medicine. CRC Press. The Journal of Biological Chemistry. Biological Signals and Receptors.

: Fat oxidation pathways

6.11: Fatty Acid Oxidation While this occurs largely on neurons, endocannabinoids have been shown to mediate these effects through glial cell receptors Hong et al. High levels of circulating lipids and higher body mass index positively correlate with better prognosis and longer survival in ALS Dupuis et al. Bacia, K. Bogdanov, M. Another portion of this ceramide is transported to the Golgi complex, where it is converted to either glucosylceramide on the cytosolic side of the Golgi via glucosylceramide synthase, or to sphingomyelin on the luminal side by sphingomyelin synthase. A family of dihydro ceramide synthases convert dihydrosphingosine to dihydroceramide. Schaffer and M.
Want to join the conversation?

Posted 7 years ago. Around 4 minutes into the video you describe from Palmitic Acid is oxidized 2 carbons at a time to give energy. Are you saying that this energy is produced in 2 ways: 1.

directly from oxidizing the chain? producing acetyl-CoA from the 2 chains oxidized or is this made with another molecule to produce Acetyl-CoA? This isn't entirely clear to me. Igors Dubanevics. Hello, Kenisha You are absolutely right. The main ATP source is AcCoA that udergoes Kreb's Cycle, which is sythesised from palmic acid oxidation.

Whilst, oxidation of a two carbon segment on palmic acid involves strippindg off hydrogens from that segment. Thus, NADH is sythesised which is processed to ATP through Electron Transport Chain. It was not me who made that video. Danielle Jettoo.

does it make a difference whether the fats are saturated or unsaturated? Hamid Hussaini. In cellular metabolism, unsaturated fat molecules contain somewhat less energy i.

The greater the degree of unsaturation in a fatty acid i. Antioxidants can protect unsaturated fat from lipid peroxidation. Video transcript - [Instructor] What I've drawn here is the chemical structure for a triacylglyceride and recall that this chemical structure is commonly what we are referring to when we talk about the type of fat found in our food as well as how fat is stored in our body.

Now the question I wanna begin to answer in this video is how do we extract ATP, the chemical energy, from this molecule because you've probably heard that fats are a very rich source of energy but how exactly do we get ATP from a structure like this?

So because these fatty acid chains are contributing to the bulk of the energy that we're extracting, we're gonna focus on how we extract ATP from these fatty acid chains in particular. And now to help us kind of get a bird's eye view of how we're able to extract ATP from these fatty acid chains, I've actually went ahead and drawn out a carbon saturated fatty acid that our body can synthesize, which is called palmitic acid.

Now if you think back to how we extracted chemical energy or ATP from glucose, you might remember that we oxidized glucose, we essentially stripped it of its electrons and we transferred those electrons to electron carrier molecules to form reduced intermediates like NADH and FADH2 and these carried the electrons found in that glucose to the electron transport chain, where we were able to produce ATP quite efficiently.

Ultimately, we just simply wanna do the same thing with our fatty acid, we wanna be able to oxidize it, extract all of those electrons, transfer them to those electron carrier molecules, NADH and FADH2, to be able to be used to produce ATP in the electron transport chain.

And from a bird's-eye view, I think the big picture takeaway is to realize that we wanna do is essentially the reverse of fatty acid synthesis, we wanna be able to take this long string of carbons and hydrogens and essentially break them down into two carbon sub-units each and as we break them up into these two carbon sub-units, we're also simultaneously oxidizing them to release all of this energy, and ultimately what we're doing is we're breaking up this large fatty acid into single molecules of acetyl-coA, and if you remember the structure of acetyl-coA looks something like this, so two carbons, one attached to an oxygen, and of course we have our co-enzyme A group, which I'm abbreviating like this.

Now notably, the energy extraction process doesn't stop there, remember that acetyl-coA is quite a versatile metabolyte when it comes to metabolism.

Odd-chain fatty acids undergo beta-oxidation in the same manner as even chain fatty acids; however, once a five-carbon chain remains, the final spiral of beta-oxidation will yield one molecule of acetyl CoA and one molecule of propionyl CoA.

This three-carbon molecule can be enzymatically converted to succinyl CoA, forming a bridge between the TCA cycle and fatty acid oxidation. VLCFA beta-oxidation in peroxisomes occurs by a process similar to mitochondrial beta-oxidation; however, some key differences exist, including the fact that different genes encode fatty acid oxidation enzymes in peroxisomes, which is significant in certain inborn errors of metabolism.

The remaining three steps are similar to the mitochondrial steps. Another notable difference involves the extent to which beta-oxidation occurs; it may occur to completion, ending in the production of acetyl CoA molecules that are able to enter the cytosol or be transported to the mitochondria bound to carnitine.

Branched-chain fatty acids also require additional enzymatic modification to enter the alpha-oxidation pathway within peroxisomes. Phytanic acid, 3,7,11,tetramethylhexadecanoic acid, requires additional peroxisomal enzymes to undergo beta-oxidation.

Phytanic acid initially activates to phytanyl CoA; then, phytanyl CoA hydroxylase alpha-hydroxylase , encoded by the PHYH gene, introduces a hydroxyl group to the alpha carbon. Pristanic acid undergoes beta-oxidation, which produces acetyl CoA and propionyl CoA in alternative rounds.

As with peroxisomal beta-oxidation of VLCFAs, this process generally ends when the carbon chain length reaches carbons, at which point the molecule is shuttled to the mitochondria by carnitine for complete oxidation to carbon dioxide and water.

Omega-oxidation of fatty acids in the endoplasmic reticulum primarily functions to hydroxylate and oxidize fatty acids to dicarboxylic acids to increase water solubility for excretion in the urine.

This enzymatic conversion relies on the cytochrome P superfamily to catalyze this reaction between xenobiotic compounds and molecular oxygen. Listed below are a few select diseases that either directly involve defective fatty acid metabolism through intrinsic enzyme deficiencies or indirectly prevent the proper functioning of fatty acid metabolism through extrinsic enzyme deficiencies.

Many, but not all, deficiencies of enzymes involved in fatty acid oxidation result in abnormal neurological development and or function early in life; a brief list of signs and symptoms appears under the selected diseases mentioned. Medium-chain acyl dehydrogenase is the most common inherited defect of fatty acid oxidation in humans; as one would expect, medium-chain carbon molecules accumulate in this disease.

Clinical manifestations of MCAD deficiency primarily present during fasting conditions and include lethargy, weakness, diaphoresis, and hypoketotic hypoglycemia, most commonly in children under the age of 5.

These abundant molecules then undergo oxidation by the cytochrome P system involved in omega-oxidation, resulting in dicarboxylic acidemia and dicarboxylic aciduria. Zellweger syndrome results from autosomal recessive mutations in the PEX genes; these DNA sequences code for peroxin proteins, which are involved in the assembly of peroxisomes.

Many different fatty acid compounds can accumulate without the oxidative machinery of peroxisomes, including VLCFAs and phytanic acid. X-ALD is a genetic deficiency of the ABCD transporters in the membrane of peroxisomes, as mentioned previously, resulting in the pathological accumulation of VLCFAs within cells and is most clinically significant when the ABCD1 transporter is absent.

The disease presents with neurodegenerative and adrenal abnormalities. Refsum disease results from a genetic deficiency of the enzyme phytanyl CoA 2-hydroxylase, which, as previously mentioned, is involved in the alpha-oxidation of phytanic acid, a breakdown product of chlorophyll.

Disclosure: Jacob Talley declares no relevant financial relationships with ineligible companies. Disclosure: Shamim Mohiuddin declares no relevant financial relationships with ineligible companies.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4. You are not required to obtain permission to distribute this article, provided that you credit the author and journal. Turn recording back on.

National Library of Medicine Rockville Pike Bethesda, MD Web Policies FOIA HHS Vulnerability Disclosure. Help Accessibility Careers. Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation. Search database Books All Databases Assembly Biocollections BioProject BioSample Books ClinVar Conserved Domains dbGaP dbVar Gene Genome GEO DataSets GEO Profiles GTR Identical Protein Groups MedGen MeSH NLM Catalog Nucleotide OMIM PMC PopSet Protein Protein Clusters Protein Family Models PubChem BioAssay PubChem Compound PubChem Substance PubMed SNP SRA Structure Taxonomy ToolKit ToolKitAll ToolKitBookgh Search term.

StatPearls [Internet]. Treasure Island FL : StatPearls Publishing; Jan-. Show details Treasure Island FL : StatPearls Publishing ; Jan-. Search term. Biochemistry, Fatty Acid Oxidation Jacob T. Author Information and Affiliations Authors Jacob T.

Affiliations 1 Lincoln Memorial University DeBusk College of Osteopathic Medicine. Introduction Oxidation of fatty acids occurs in multiple regions of the cell within the human body; the mitochondria, in which only beta-oxidation occurs; the peroxisome, where alpha- and beta-oxidation occur; and omega-oxidation, which occurs in the endoplasmic reticulum.

Fundamentals Mitochondrial beta-oxidation can be used to supply acetyl CoA to two separate pathways, depending on which tissue oxidation occurs. Cellular Level Important concepts pertaining to the regulation of mitochondrial beta-oxidation, cellular handling, and transport of fatty acids will be discussed here.

Molecular Level In a similar fashion to previous sections, the process and enzymatic steps of the beta-oxidation spiral will primarily undergo discussion with alternative oxidation pathways mentioned later as they pertain to and produce metabolic products destined for mitochondrial beta-oxidation.

Clinical Significance Listed below are a few select diseases that either directly involve defective fatty acid metabolism through intrinsic enzyme deficiencies or indirectly prevent the proper functioning of fatty acid metabolism through extrinsic enzyme deficiencies.

MCAD Deficiency Medium-chain acyl dehydrogenase is the most common inherited defect of fatty acid oxidation in humans; as one would expect, medium-chain carbon molecules accumulate in this disease.

Zellweger Syndrome Zellweger syndrome results from autosomal recessive mutations in the PEX genes; these DNA sequences code for peroxin proteins, which are involved in the assembly of peroxisomes.

Review Questions Access free multiple choice questions on this topic. Comment on this article. References 1. Houten SM, Violante S, Ventura FV, Wanders RJ. The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders.

Annu Rev Physiol. de Lima FD, Correia AL, Teixeira Dda S, da Silva Neto DV, Fernandes ÍS, Viana MB, Petitto M, da Silva Sampaio RA, Chaves SN, Alves ST, Dantas RA, Mota MR.

Acute metabolic response to fasted and postprandial exercise. Int J Gen Med. Schönfeld P, Reiser G. Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Aging Dis. Alves-Bezerra M, Cohen DE.

Triglyceride Metabolism in the Liver. Mitochondrial Fatty Acid β-Oxidation The fatty acid β-oxidation pathway: Fatty acid β-oxidation is the process of breaking down a long-chain acyl-CoA molecule to acetyl-CoA molecules.

Figure 3. Key regulation sites of fatty acid β-oxidation Fatty acid β-oxidation is regulated at multiple levels. Allosteric control of fatty acid β-oxidation: The activity of the enzymes of fatty acid β-oxidation is affected by the level of the products of their reactions [16].

Transcriptional regulation of fatty acid β-oxidation: The proteins involved in fatty acid β-oxidation are regulated by both transcriptional and post-transcriptional mechanisms.

Conclusions Fatty acid β-oxidation is major metabolic pathway that is responsible for the mitochondrial breakdown of long-chain acyl-CoA to acetyl-CoA. References Lopaschuk, G. and Stanley, W. Myocardial fatty acid metabolism in health and disease.

Physiol Rev. Su, X. and Abumrad, N. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Glatz, J. and Bonen, A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Folmes, C. and Lopaschuk, G.

Regulation of fatty acid oxidation of the heart. In: Mitochondria: The Dynamic Organelle 1st Edition , pp. Schaffer and M.

Suleiman eds. Nickerson, J. Protein-mediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals.

Bonen, A. and Glatz, J. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology Bethesda , 22 , Holloway, G. Acta Physiol. Oxford , , Tong, L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery.

Life Sci. Schreurs, M. and van der Leij, F. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Adam, T. and Essop, M. AMPK activation represses the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase: Role of nuclear respiratory factor Schulz, H.

Oxidation of fatty acids in eukaryotes. In: Biochemistry of Lipids, Lipoproteins and Membranes 5th Edition , pp. Vance and J. Vance eds. Mazumder, R. and Ochoa, S. Metabolism of propionic acid in animal tissues. Methylmalonyl co-enzyme A mutase holoenzyme. Kaziro, Y. Biotin and propionyl carboxylase.

USA, 46 , Beck, W. Formation of succinate. Diedrich, M. and Henschel, K. The natural occurrence of unusual fatty-acids. Odd numbered fatty-acids. Nahrung , 34 , Regulation of fatty acid oxidation in heart. Eaton, S. Control of mitochondrial β-oxidation flux.

Lipid Res. Huss, J. and Kelly, D. Nuclear receptor signaling and cardiac energetics. Dressel, U. and Muscat, G. Son, N. and Goldberg, I. Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice.

Lin, J. and Spiegelman, B. Metabolic control through the PGC-1 family of transcription coactivators. Jensen, T.

Skeletal muscle energy metabolism during exercise Energy boosters for improved memory contrast oxidatiln this involved, Pathwajs transport mechanism, VLCFAs are not dependent Body composition monitoring carnitine for transport into peroxisomes; the transport of branched-chain fatty acids destined for oxidatiion is similar to this process, and Fat oxidation pathways previously mentioned, is substrate-dependent. The succinyl-CoA formed then enters the citric acid cycle. Interestingly, 3-ketoacyl-CoA can also inhibit enoyl-CoA hydratase and acyl-CoA dehydrogenase [17]. Article PubMed PubMed Central Google Scholar Costill, D. If excess acetyl CoA is created and overloads the capacity of the Krebs cycle, the acetyl CoA can be used to synthesize ketone bodies. Yu, M. In these situations, continued aerobic production of ATP fuels the regeneration of PCr such that it can be completely recovered in 60— s ref.
Fatty Acid beta-Oxidation Acta Pxidation. A side effect of using ketones as Fat oxidation pathways is pathwwys sweet alcohol smell on the breath. Frandsen, J. However, this acetyl CoA needs to be transported into cytosol where the synthesis of fatty acids and cholesterol occurs. Carter, S.
StatPearls [Internet].

Within the intestinal cells, these triglycerides are packaged along with cholesterol molecules in phospholipid vesicles called chylomicrons. The chylomicrons enable fats and cholesterol to move within the aqueous environment of your lymphatic and circulatory systems.

Chylomicrons leave the enterocytes by exocytosis and enter the lymphatic system via lacteals in the villi of the intestine. From the lymphatic system, the chylomicrons are transported to the circulatory system. Once in the circulation, they can either go to the liver or be stored in fat cells adipocytes that comprise adipose fat tissue found throughout the body.

To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis , takes place in the cytoplasm.

The resulting fatty acids are oxidized by β-oxidation into acetyl CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis directly enters the glycolysis pathway as DHAP. Because one triglyceride molecule yields three fatty acid molecules with as much as 16 or more carbons in each one, fat molecules yield more energy than carbohydrates and are an important source of energy for the human body.

Triglycerides yield more than twice the energy per unit mass when compared to carbohydrates and proteins. Therefore, when glucose levels are low, triglycerides can be converted into acetyl CoA molecules and used to generate ATP through aerobic respiration.

The breakdown of fatty acids, called fatty acid oxidation or beta β -oxidation , begins in the cytoplasm, where fatty acids are converted into fatty acyl CoA molecules. This fatty acyl CoA combines with carnitine to create a fatty acyl carnitine molecule, which helps to transport the fatty acid across the mitochondrial membrane.

Once inside the mitochondrial matrix, the fatty acyl carnitine molecule is converted back into fatty acyl CoA and then into acetyl CoA. The newly formed acetyl CoA enters the Krebs cycle and is used to produce ATP in the same way as acetyl CoA derived from pyruvate.

Figure 3. Click for a larger image. During fatty acid oxidation, triglycerides can be broken down into acetyl CoA molecules and used for energy when glucose levels are low.

If excessive acetyl CoA is created from the oxidation of fatty acids and the Krebs cycle is overloaded and cannot handle it, the acetyl CoA is diverted to create ketone bodies. These ketone bodies can serve as a fuel source if glucose levels are too low in the body. Ketones serve as fuel in times of prolonged starvation or when patients suffer from uncontrolled diabetes and cannot utilize most of the circulating glucose.

In both cases, fat stores are liberated to generate energy through the Krebs cycle and will generate ketone bodies when too much acetyl CoA accumulates. In this ketone synthesis reaction, excess acetyl CoA is converted into hydroxymethylglutaryl CoA HMG CoA.

HMG CoA is a precursor of cholesterol and is an intermediate that is subsequently converted into β-hydroxybutyrate, the primary ketone body in the blood. Figure 4. Excess acetyl CoA is diverted from the Krebs cycle to the ketogenesis pathway.

This reaction occurs in the mitochondria of liver cells. The result is the production of β-hydroxybutyrate, the primary ketone body found in the blood. Organs that have classically been thought to be dependent solely on glucose, such as the brain, can actually use ketones as an alternative energy source.

This keeps the brain functioning when glucose is limited. When ketones are produced faster than they can be used, they can be broken down into CO 2 and acetone. The acetone is removed by exhalation. This effect provides one way of telling if a diabetic is properly controlling the disease.

The carbon dioxide produced can acidify the blood, leading to diabetic ketoacidosis, a dangerous condition in diabetics.

Ketones oxidize to produce energy for the brain. beta β -hydroxybutyrate is oxidized to acetoacetate and NADH is released. An HS-CoA molecule is added to acetoacetate, forming acetoacetyl CoA. The carbon within the acetoacetyl CoA that is not bonded to the CoA then detaches, splitting the molecule in two.

This carbon then attaches to another free HS-CoA, resulting in two acetyl CoA molecules. These two acetyl CoA molecules are then processed through the Krebs cycle to generate energy. Figure 5. When glucose is limited, ketone bodies can be oxidized to produce acetyl CoA to be used in the Krebs cycle to generate energy.

When glucose levels are plentiful, the excess acetyl CoA generated by glycolysis can be converted into fatty acids, triglycerides, cholesterol, steroids, and bile salts. This process, called lipogenesis , creates lipids fat from the acetyl CoA and takes place in the cytoplasm of adipocytes fat cells and hepatocytes liver cells.

When you eat more glucose or carbohydrates than your body needs, your system uses acetyl CoA to turn the excess into fat. Although there are several metabolic sources of acetyl CoA, it is most commonly derived from glycolysis.

Acetyl CoA availability is significant, because it initiates lipogenesis. Lipogenesis begins with acetyl CoA and advances by the subsequent addition of two carbon atoms from another acetyl CoA; this process is repeated until fatty acids are the appropriate length.

Because this is a bond-creating anabolic process, ATP is consumed. However, the creation of triglycerides and lipids is an efficient way of storing the energy available in carbohydrates. Triglycerides and lipids, high-energy molecules, are stored in adipose tissue until they are needed. Although lipogenesis occurs in the cytoplasm, the necessary acetyl CoA is created in the mitochondria and cannot be transported across the mitochondrial membrane.

To solve this problem, pyruvate is converted into both oxaloacetate and acetyl CoA. Two different enzymes are required for these conversions. Oxaloacetate forms via the action of pyruvate carboxylase, whereas the action of pyruvate dehydrogenase creates acetyl CoA.

Oxaloacetate and acetyl CoA combine to form citrate, which can cross the mitochondrial membrane and enter the cytoplasm. This gradient is in place to align with cellular function.

The ER has a low concentration since a more fluid membrane allows for easier protein insertion and folding, whereas a high sphingolipid concentration in the plasma membrane and endosomes creates thicker and less permeable barriers to outside molecules van Meer et al.

Another structural component that sphingolipids take part in are lipid rafts. These lipid rafts are the result of the strong intermolecular forces between individual sphingolipid molecules, driving a phase separation of the sphingolipids from the phospholipid-rich outer membrane Brown and London, ; Bacia et al.

Present on membranes with high concentration of sphingolipids and cholesterol, lipid rafts act as major anchoring sites for proteins.

Proteins that integrate with these rafts have been implicated in a host of processes, ranging from endocytic pathway sorting to antigen-responsive signaling Posse de Chaves and Sipione, Cholesterol plays a major role in determining cellular membrane flexibility and permeability.

This is achieved through complex interactions of cholesterol molecules with the phospholipid bilayer. The structurally rigid planar ring structure—the sterol group, is the major facilitator of this de Meyer and Smit, The polar nature of this group causes close interaction of the cholesterol molecules with phospholipids.

This causes a condensation effect, whereby the lipid bilayer in these regions becomes tightly packed and ordered, creating a lipid ordered l o phase Ege et al.

In this phase, the membrane is still considered to be fluid, but the lipids within are in a much more ordered orientation. Such condensation also decreases membrane permeability in these regions Bastiaanse et al.

Interestingly, the association between phospholipids and cholesterol is dependent on phospholipid subtype. Phosphatidylcholine is the most highly associated, followed by phosphatidylserine and phosphatidylethanolamine. This is due to the nature of their sidechains, where cholesterol prefers to associate with saturated fatty acyl chains, to promote closer packing Ohvo-Rekilä et al.

Depending on both the concentration of cholesterol, as well as the temperature of the membrane, cholesterol can have differing effects. At low concentrations cholesterol has a minor effect on membrane composition, and most phospholipid membranes are in a lipid disordered state.

As cholesterol concentration increases, the membrane becomes more ordered, until crystallization begins to occur Bach and Wachtel, At high temperatures, the tight packing of fatty acyl chains with cholesterol decreases the fluidity of the membrane, while at low temperatures, the presence of cholesterol hinders the tight packing that is required for highly ordered membranes Khan et al.

Thus, cholesterol acts as a buffer for temperature-dependent membrane fluidity, limiting the extremes typically observed in a cholesterol-free membrane.

Despite these biophysical effects of cholesterol, the exact mechanism behind them is still unknown. Cholesterol and sphingolipids also show close associations in the brain through lipid rafts.

Along with the phase separation observed as the result of sphingolipid association, it is also understood to occur as the result of close associations between sphingolipids and cholesterol.

A number of calorimetric and cholesterol partitioning experiments have shown that the affinity of cholesterol for sphingolipids is above that of phospholipids due to the amide linkage found in sphingolipids.

Therefore, such close associations drive further phase separation between the sphingolipids and phospholipids, promoting the formation of these raft structures.

Furthermore, the liquid ordered state, as facilitated by cholesterol, is hypothesized to be the phase required for lipid raft formation Silvius, As bioactive molecules, lipids take part in a wide range of cellular signaling processes.

Here, signaling processes will only be reviewed in the context of the CNS. Fatty acids and their derivatives have been well characterized as drivers of intracellular signaling processes Graber et al. One class that show particularly well-defined roles are the PUFAs. As previously mentioned, the brain is enriched in two major PUFAs; arachidonic acid and docosahexaenoic acid.

Consequentially, PUFAs have been implicated in neuronal signaling processes controling neurogenesis, brain vesicular activity, central glucose homeostasis, mood and cognition Bazinet and Layé, Unmodified PUFAs primarily act upon fatty acid-activated receptors.

The most well studied family of receptors are the PPARs. In the brain, PPARδ and PPARβ are involved in the regulation of fatty acid metabolism and inflammatory responses Tyagi et al. PUFAs also downregulate SREBP1 activity, which is involved in de novo lipogenesis Infantino et al.

PUFAs are also involved in more distinct signaling pathways. Endocannabinoids are fatty acid derivatives, with the major forms in the brain being the arachidonic acid derivatives anandamide, and 2-arachidonoylglycerol.

These bind to cannabinoid receptor type 1 and 2 on both neurons and glia Matsuda et al. Acting as retrograde messengers at type 1 receptors, they supress neurotransmitter release Kim and Thayer, At excitatory and inhibitory synapses this mediates short-term synaptic plasticity and long term depression Gerdeman et al.

While this occurs largely on neurons, endocannabinoids have been shown to mediate these effects through glial cell receptors Hong et al. PUFAs also play a major role in inflammatory signaling pathways. Interestingly, the structure of the PUFA can significantly alter inflammatory response, where omega-3 fatty acids have an anti-inflammatory effect in the brain Calder, , and omega-6 fatty acids have a pro-inflammatory effect Patterson et al.

Consequentially, expression of docosahexaenoic acid and its intermediates have been shown to have a potent anti-inflammatory effect by lowering levels of pro-inflammatory cytokines in the brain following LPS administration Delpech et al.

Studies have also shown that diets rich in docosahexaenoic acid lower the risk of neuroinflammatory diseases Minogue et al. Arachidonic acid intermediates, however, are potent neuroinflammatory enhancers. Major metabolites of arachidonic acid are the prostaglandins, which have been heavily implicated in inflammatory responses throughout the body.

Their expression is particularly high under pathogenic neuroinflammatory conditions, suggesting a critical role in brain pro-inflammatory responses Ricciotti and FitzGerald, ; Lima et al. Phosphorylated forms of phosphatidylinositol activate phospholipase C, creating inositol triphosphate IP 3 and diacylglycerol Berridge and Irvine, ; Vanhaesebroeck et al.

IP 3 is transported rapidly to the cytosol where it promotes calcium release Berridge, In this way, phosphatidylinositol signaling in the brain has been linked to inter-neuronal communication through vesicular-mediated action of muscarinic and serotonergic receptors.

Diacylglycerol can either be phosphorylated to give the phospholipid precursor phosphatidic acid Rodriguez de Turco et al. In this way, diacylglycerol can give rise to a host of signaling processes, through two diverging pathways.

Sphingolipids also play a major signaling role in the brain. The brain contains a high concentration of gangliosides, which are synthesized through the addition of sialic acid to glycosphingolipid monomers Yu et al.

Throughout development, the composition of brain gangliosides switches from predominantly simple gangliosides GM3 to complex gangliosides GM1a.

Such changes in the expression patterns of gangliosides suggest a role in brain development Yu et al. Taken together, gangliosides have been shown to have major roles in membrane protein modulation, cell-cell adhesion, axonal growth, synaptic transmission, neural development and differentiation and receptor regulation Yu et al.

In many cases, a combination of lipids facilitates signaling events. This is particularly the case for lipid rafts.

The close association of phospholipids, cholesterol and sphingolipids leads to the formation of lipid rafts Simons and Sampaio, Lipid rafts serve as major organizing centers for proteins and signaling molecules, acting as essential cellular signaling components Allen et al.

In the brain, lipid rafts have been implicated in ionotropic receptor localization, binding and trafficking, neurotransmitter transport, cytoskeletal rearrangement through tubulin and actin remodeling, exocytosis, organization of G-protein coupled receptor machinery assembly for downstream signaling, cell surface receptor clustering, metabolism, neuronal growth and development, and redox signaling Allen et al.

Thus, lipid rafts are the central organizing space for all major classes of neuronal processes. In summary, neuronal lipid signaling occurs through a range of processes, some driven by individual lipid classes, while others require more complex associations.

The result is an incredibly intricate system that has multiple layers of redundancy, ensuring tightly controlled processes. ALS is a progressive neurodegenerative disorder that is characterized by the selective degeneration of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord.

The progressive degeneration of these motor neurons leads to paralysis, and eventual death within 2—5 years from diagnosis Kiernan et al. Despite the breadth of research on ALS, its etiology is still not well understood. A growing number of in vitro and in vivo studies have begun to investigate metabolism as a means of explaining the neuropathology observed in ALS.

While a number of metabolic hallmarks have been observed in ALS patients Reyes et al. A major site of interest for lipid studies in ALS is skeletal muscle. Many studies have suggested that skeletal muscle is a major source of dysregulated lipid metabolism.

Indeed, a defined switch from glucose-based to lipid-based metabolism is an early pathological event in ALS muscle Palamiuc et al. Furthermore, significant alterations in glycosphingolipid metabolism in the muscle of ALS mice impacts muscle innervation and motor recovery Henriques et al.

Thus, dysregulation in lipid metabolism in skeletal muscle have been linked to pathological outcomes. Having reviewed the multiple functions of lipids individually, we will now frame the dysfunctions caused by abnormal lipid metabolism in ALS in this way. A growing focal point in ALS research is the role of lipids as an energy substrate.

Given consistent observations of altered lipid metabolism in skeletal muscle, research has begun to consider neuronal lipid energy use in ALS. Such research, however, is still in its infancy.

Perhaps the most compelling evidence towards a pathological role for lipid metabolism in ALS neurons is through CNS-specific oxidative stress, in which a range of lipid-derived oxidative pathway intermediates have been observed at heightened levels in the CNS Tohgi et al.

With the discovery of the superoxide dismutase-1 SOD1 mutant in ALS, researchers were quick to pin the cause of oxidative stress on this mutation Rosen et al.

Further studies have determined that while the SOD1 mutation may contribute to oxidative stress, it is not the major cause.

This is supported by the presence of oxidative stress in non-SOD1 ALS Duan et al. In light of this, researchers have considered energetic substrate metabolism as a source of oxidative stress. During normal neuronal activity, oxidative stress is kept relatively low Almeida et al.

In ALS, however, an increased demand for energy is placed on the motor neurons. Despite this, brain and spinal cord glucose use Hatazawa et al. Similarly, reduced lactate transport and metabolism Lee et al. It is therefore hypothesized that alternate substrates are metabolized to meet the energy requirements of the brain.

Indeed, in mouse models of ALS, lipid catabolism and clearance to peripheral tissues is significantly increased Fergani et al. Similarly, elevated levels of ketone bodies have been observed in ALS patient cerebrospinal fluid Blasco et al.

With the suggestion of increased peripheral lipid availability, it is plausible that metabolic utilization of these lipids would increase. Consequentially, studies of mouse models of ALS, as well as in ALS patients, show that markers of oxidative stress and lipid peroxidation are significantly elevated in brain and spinal cord tissue, via lipid-centric pathways Simpson et al.

Hence, an increased focus on lipid metabolites as a fuel source would inevitably lead to increased oxidative stress, which would have number of deleterious outcomes Figure 6.

Figure 6. Fatty acid oxidation is a major contributor to reactive oxygen species production, which is increased in amyotrophic lateral sclerosis ALS. Although fatty acids are not the obligate substrate for energy production in the cell, β-oxidation of fatty acids generates a substantial amount of reactive oxygen species as a by-product.

In turn, these promote a number of harmful oxidative effects including lipid peroxidation, protein oxidation, DNA damage, and apoptosis. As neurons are not effectively equipped to deal with oxidative stress, these harmful effects are multiplied, contributing to neurodegeneration.

In ALS patient muscle, peroxisome proliferator-activated receptor gamma coactivator 1-α PGC-1α , a master regulator of normal mitochondrial function and biogenesis, is downregulated, leading to modifications in fatty acid signaling, and increased β-oxidation Barroso et al.

In mouse models of ALS, downregulation of PGC-1α has been shown to hasten disease progression Eschbach et al. Survival, however, is not extended. Together, these findings highlight the essential link between fatty acid oxidation and disease, while suggesting that muscle may not be the primary target.

Application of these findings to a neuronal model, therefore, would be expected to have more drastic effects, given the poorer oxidative defense capabilities of the CNS.

Interestingly, when PGC-1α is upregulated in the CNS, mitochondrial function is not only improved centrally, but motor function and survival are also drastically improved Zhao et al.

Therefore, a strong case can be made for the role of PGC-1α in maintaining CNS-driven fatty acid metabolism. In a similar fashion, the stearoyl-CoA desaturase 1 SCD-1 gene has been implicated in ALS. SCD-1 is a key enzyme in fatty acid metabolism regulation, and directly alters the levels of β-oxidation that occur in the mitochondria Ntambi, ; Ntambi et al.

In mouse models of ALS, as well as ALS patient muscle samples, SCD-1 has been shown to be downregulated Pradat et al. While downregulation of SCD-1 may explain increased expression of β-oxidation enzymes, increased energy expenditure, and reduced fat storage in ALS mice Dupuis et al.

In mouse models of ALS, it has been shown that membrane fluidity in the brain and spinal cord decreases significantly over the course of disease Miana-Mena et al.

There are a number of potential hypotheses for why this may occur. The first involves central PUFA concentrations. The brain contains a very high concentration of PUFAs, which are stored as phosphatidylethanolamine arachidonic acid or phosphatidylserine docosahexaenoic acid in neuronal membranes Bazinet and Layé, Due to the highly unsaturated nature of these fatty acids, neuronal membranes rich in phosphatidylethanolamine and phosphatidylserine are significantly less fluid.

In ALS, docosahexaenoic acid levels are significantly increased in the brain, which may result in more rigid membranes Ilieva et al. Another theory that supports these findings involves lipid peroxidation. PUFAs are particularly sensitive substrates in lipid peroxidation reactions.

Due to the highly oxidative environment of the brain in ALS, lipid peroxidation occurs at a higher rate. This is supported somewhat by the observation that high levels of lipid peroxidation intermediates exist in ALS patient spinal cord Shibata et al.

Since a large majority of signaling lipids and proteins are found within membranes, it is possible that decreases in fluidity will decrease their mobility, impairing their function, and leading to pathological outcomes through interruptions to signaling pathways.

Due to the limited number of studies in this area, further research is needed to determine the role of lipids in cellular structure and integrity in ALS.

Due to the diverse nature of lipid signaling in the brain, the potential for multifactorial pathways for lipid dysfunction is great. PUFAs are known to bind to a number of essential metabolic transcription factors, such as LXR, which regulate lipid levels in the CNS.

Specifically, LXRs modulate cholesterol levels, acting as endogenous cholesterol sensors. In ALS, disruptions to LXR signaling have been implicated in dysfunctional signaling cascades, leading to motor neuron and glial cell damage in SOD1 mice.

LXR knockout mice show neuroinflammatory responses leading to motor neuron loss, and neuromuscular junction defects Mouzat et al. A number of PUFAs also act as pro- or anti-inflammatory signaling molecules. For example, the PUFAs eicosapentaenoic acid and arachidonic acid are oxidized to form prostaglandins or leukotrienes—essential central inflammatory molecules.

In ALS patients, elevated levels of prostaglandin E2 are observed in serum and cerebrospinal fluid Iłzecka, Furthermore, pharmacological inhibition of the prostaglandin E2 receptor Liang et al. In a broader sense, disruption in signaling can arise from more than fatty acid-centric pathways.

Concurrent with lipid peroxidation affecting membrane fluidity, peroxidation also affects the composition of lipid rafts, and excitotoxic signaling pathways Zhai et al.

Lipid rafts act as major structures for protein binding and signaling in the CNS, suggesting that significant variation in raft composition may affect signaling processes through alterations in protein association.

Indeed, proteomic studies on lipid raft composition in the spinal cord of SOD1 mice show a total of 67 differentially expressed proteins, with major roles in vesicular transport, neurotransmitter synthesis and release, cytoskeletal organization and metabolism Zhai et al.

In terms of excitotoxic outcomes, lipid peroxidation produces a number of damaging by-products, such as 4-hydroxynonenal. In ALS patients, higher levels of these molecules in the spinal cord has been linked with modification of the astrocytic glutamate transporter EAAT2 Pedersen et al.

Given that astrocytic EAATs play a key role in protecting against microglial glutamate-induced neuronal death, it is possible that reduced expression of EAAT2 and glutamate excitotoxicity in ALS Rothstein et al.

Interestingly, EAAT2 is a protein that is associated almost entirely with lipid rafts Butchbach et al. Therefore, it stands to reason that changes in lipid composition, as observed in ALS, will significantly affect EAAT2 activity.

A curious finding amongst mouse models of ALS, as well as ALS patients, is an increase in sphingolipids in the central nervous system, due to oxidative stress.

The initial assumption was that aberrant sphingolipid metabolism was causing a pathological upregulation of sphingolipid metabolites, leading to neurodegenerative outcomes Cutler et al.

More recently, it has been shown that glycosphingolipid metabolites are significantly increased in skeletal muscle, but decreased in the CNS Dodge et al. Since pathological outcomes are observed in both tissue types, it is possible that glycosphingolipids exert their effects in a dose dependent manner, where chronically high or low levels affect signaling fidelity, leading to pathology Dodge et al.

In light of the proposed mechanisms for dysregulation of lipid pathways in ALS, treatments targeting these pathways have generated significant interest.

High levels of circulating lipids and higher body mass index positively correlate with better prognosis and longer survival in ALS Dupuis et al. As such a number of dietary interventions have been trialed for ALS treatment. High fat diets exert a modest decrease in disease progression in a mouse model of ALS Dupuis et al.

Despite a large body of data to suggest that the adoption of high-calorie or high-protein diets may be of some benefit for ALS patients Silva et al. While druggable targets for lipid metabolism are plentiful, therapeutics to target these pathways in ALS remain largely untested.

One promising therapeutic intervention so far relates to the modulation of the balance between fatty acid and glucose oxidation. It has recently been shown that SOD1 mice exhibit a preferential switch towards fatty acid oxidation, and that a reversal of this switch to promote glucose oxidation through treatment with dichloroacetate leads to significant improvements in motor function Palamiuc et al.

While Palamiuc et al. Whether dichloroacetate improves redox status in motor neurons in ALS remains to be investigated. Another compound that has shown promise is conduritol B epoxide, a potent β-Glucocerebrosidase that modulates sphingolipid metabolism.

By increasing the levels of glucosylceramide in SOD1 mice, conduritol B epoxide not only attenuates the dysregulation of genes that are involved in pathogenic pathways, it also preserves neuromuscular junction function and rescues motor neurons from death in a mouse model of ALS Henriques et al.

In this regard, inhibition of glucosylceramide synthesis has been shown to hasten disease progression in SOD1 mice Dodge et al. Thus, neuronal and muscular glycosphingolipids serve as an exciting target for further research and therapeutic development for ALS.

The neuronal metabolism of lipids is a system of great depth, with functional outcomes ranging from energy substrate availability through to nuanced signaling pathways. Despite this, it remains an area of many unknowns. In ALS, neuronal lipid metabolism is dysregulated in a number of ways, affecting energy use, structural integrity, and signaling processes.

In terms of energy use, neurons metabolize a greater proportion of lipid substrates, increasing oxidative stress. This leads to inflammation, mitochondrial dysfunction, metabolic dysfunction and excitotoxicity. At a structural level, altered lipid metabolism disrupts intracellular lipid levels, leading to cytoskeletal defects, and neuromuscular junction denervation.

From a signaling perspective, altered lipid metabolism affects the composition of lipid rafts, disrupting important signaling processes, leading to defects in neurotransmitter synthesis and release, cytoskeletal defects, and impaired intracellular transport Figure 7. Figure 7.

Dysregulated lipid metabolism exerts a multifaceted effect on neurons in ALS. Dysregulation of neuronal lipid metabolism in ALS impacts energy use, structural integrity and signaling processes.

Increased use of lipid as an energy substrate leads to increased oxidative stress. This exacerbates inflammation, mitochondrial dysfunction, metabolic dysfunction and excitotoxicity.

Altered lipid metabolism also disrupts intracellular lipids leading to cytoskeletal defects and the denervation of neuromuscular junctions. Finally, changes in lipid metabolism impacts the composition of lipid rafts. This disrupts signaling processes that are crucial in regulating neurotransmitter synthesis and release, cytoskeletal integrity and intracellular transport.

While recent research into the role of glycosphingolipid metabolism in ALS has opened avenues for the development of potential novel therapeutics, more studies are needed to understand the functional consequences of alterations in lipid metabolism in ALS as a whole.

This, in turn, will ultimately lead to more promising treatment opportunities, the beginnings of which are already proving to be fruitful. TJT conducted the literature search and wrote the manuscript.

FJS produced all artwork. FJS, EJW and STN critically reviewed the manuscript. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

TJT is supported by an Australian Postgraduate Award from the University of Queensland, and a Postgraduate top-up grant from the Motor Neurone Disease Research Institute of Australia.

Abu-Elheiga, L. Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms.

doi: PubMed Abstract CrossRef Full Text Google Scholar. Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms.

U S A 92, — Agostoni, C. Fatty acids: their biochemical and functional classification. PubMed Abstract Google Scholar. Ahmadian, M. Triacylglycerol metabolism in adipose tissue. Future Lipidol. Alexson, S. A direct comparison between peroxisomal and mitochondrial preferences for fatty-acyl β-oxidation predicts channelling of medium-chain and very-long-chain unsaturated fatty acids to peroxisomes.

Acta , 1— Ali, M. Assess the nature of cholesterol-lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayers. U S A , — Allen, J. Lipid raft microdomains and neurotransmitter signalling.

Almeida, A. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructokinase pathway. Cell Biol. Andrus, P. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Antonsson, B. Phosphatidylinositol synthase from mammalian tissues. Acta , — Bach, D. Bacia, K. Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Balaban, R. Regulation of oxidative phosphorylation in the mammalian cell.

Balasse, E. Inhibition of ketogenesis by ketone bodies in fasting humans. Metabolism 24, — Barroso, E. Endocrinology , — Bastiaanse, E. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res. Basu, S. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain.

Enzymatic synthesis of glucocerebroside by a glucosyltransferase from embryonic chicken brain. Baumann, N. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Bazinet, R.

Polyunsaturated fatty acids and their metabolites in brain function and disease. Becker, I. Bell, R. Diglyceride lipase: a pathway for arachidonate release from human platelets.

U S A 76, — Benarroch, E. Lipid rafts, protein scaffolds, and neurologic disease. Neurology 69, — Berridge, M. Inositol trisphosphate and calcium signalling mechanisms. Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Nature , — PubMed Abstract CrossRef Full Text. Blasco, H. PLoS One 5:e Bloch, K. The biological synthesis of cholesterol. Science , 19— Sterol molecule: structure, biosynthesis, and function.

Steroids 57, — Bloj, B. Rat liver proteins capable of transferring phosphatidylethanolamine. Purification and transfer activity for other phospholipids and cholesterol.

Blom, T. Synthesis and biosynthetic trafficking of membrane lipids. Cold Spring Harb. Blusztajn, J. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis. Neural Transm. Bogdanov, M. Increased oxidative damage to DNA in ALS patients. Free Radic. Boggs, J. Lipid intermolecular hydrogen bonding: influence on structural organization and membrane function.

Braun, R. Neurotoxic kDa TAR DNA-binding protein TDP triggers mitochondrion-dependent programmed cell death in yeast. Bressler, R. Studies on the mechanism of fatty acid synthesis. The product of the reaction and the role of sulfhydryl groups in the synthesis of fatty acids.

Bristol, L. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Brown, D. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. Browne, S.

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS.

Butchbach, M. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.

Calder, P. Omega-3 fatty acids and inflammatory processes. Nutrients 2, — Carri, M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Castle, J. ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus. PLoS One 4:e Chen, J.

Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Chester, M. IUPAC-IUB Joint commission on biochemical nomenclature JCBN.

Nomenclature of glycolipids—recommendations Chevaleyre, V. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38, — Chirala, S. Human fatty acid synthase: role of interdomain in the formation of catalytically active synthase dimer.

U S A 98, — Clark, B. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein StAR.

Coleman, R. Evidence that biosynthesis of phosphatidylethanolamine, phosphatidylcholine, and triacylglycerol occurs on the cytoplasmic side of microsomal vesicles. Enzymes of triacylglycerol synthesis and their regulation.

Lipid Res. Crugnola, V. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Cutler, R. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.

Da Cruz, S. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi.

de Kroon, A. Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane?

Delpech, J. Neuropsychopharmacology 40, — Demarquoy, J. Crosstalk between mitochondria and peroxisomes. World J. de Meyer, F. Effect of cholesterol on the structure of a phospholipid bilayer. Dennis, E. Intracellular sites of lipid synthesis and the biogenesis of mitochondria. Desport, J.

Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Di Paola, M. Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition.

Dircks, L. Acyltransferases of de novo glycerophospholipid biosynthesis. Dodge, J. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis.

Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Dole, V. Particulate fat in lymph and blood. Dorst, J. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study.

Lateral Scler. Frontotemporal Degener. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. Duan, W. Mutant TAR DNA-binding protein induces oxidative injury in motor neuron-like cell.

Neuroscience , — Dupuis, L. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, — Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Eaton, S. Mammalian mitochondrial β-oxidation. Ebert, D. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. Ege, C. Ellis, N. The influence of the character of the ration upon the composition of the body fat of hogs.

The effect of food fat upon body, as shown by the separation of the individual fatty acids of the body fat. Eschbach, J. PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis.

Fadeel, B. The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.

Fagone, P. Membrane phospholipid synthesis and endoplasmic reticulum function. Fergani, A. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis.

Field, F. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. Fredrikson, G. Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol.

Fukasawa, M. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. Gallegos, A. Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics.

Biochemistry 40, — Garber, A. Hepatic ketogenesis and gluconeogenesis in humans. Gatta, A. A new family of StART domain proteins at membrane contact sites has a role in ER-PM sterol transport.

Elife 4:e Gault, C. An overview of sphingolipid metabolism: from synthesis to breakdown. Gerdeman, G. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Glaser, P.

Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehydephosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 34, — Glatz, J. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism.

Prostaglandins Leukot. Fatty Acids 57, — Goldberg, I. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CDmediated pathways. Graber, R.

Fatty acids and cell signal transduction. Lipid Mediat. Cell Signal. Guo, M. Neuronal specific increase of phosphatidylserine by docosahexaenoic acid. Ha, J. Inhibition of fatty acid synthesis by expression of an acetyl-CoA carboxylase-specific ribozyme gene.

U S A 91, — Cloning of human acetyl-CoA carboxylase-beta and its unique features. U S A 93, — Haemmerle, G. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle and testis. Hamilton, J. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders.

Han, D. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. Hanada, K. Intracellular trafficking of ceramide by ceramide transfer protein. B Phys. Molecular machinery for non-vesicular trafficking of ceramide. Hatazawa, J.

Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. Helmkamp, G. Phospholipid exchange between membranes. Purification of bovine brain proteins that preferentially catalyze the transfer of phosphatidylinositol. Henriques, A. Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis.

PLoS One e Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Inhibition of β-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis. Herrero-Mendez, A.

Herzig, S. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ. Hiltunen, J. β-oxidation—strategies for the metabolism of a wide variety of acyl-CoA esters. Hinkle, P. Mechanistic stoichiometry of mitochondrial oxidative phosphorylation.

Biochemistry 30, — Hirano, M. VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Aging 36, Hong, S. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells.

Autacoids in anti-inflammation. Hopkins, T. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.

Horibata, Y. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. Hörl, G. Sequential synthesis and methylation of phosphatidylethanolamine promote lipid droplet biosynthesis and stability in tissue culture and in vivo.

Howlett, A. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Lipids , 53— Huijbregts, R. Rapid transmembrane movement of newly synthesized phosphatidylethanolamine across the inner membrane of Escherichia coli.

Huitema, K. Identification of a family of animal sphingomyelin synthases. EMBO J. Husemann, J. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system.

Glia 40, — Hussain, G. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury.

PLoS One 8:e Iguchi, Y. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP linked to TDP proteinopathies.

Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Ilieva, E. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain , — Iłzecka, J. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.

Acta Neurol. Infantino, V. Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA. Itoh, Y. Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo.

Jackson, R. Lipoprotein structure and metabolism. Jakobsson, A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Jansen, G. Jeckel, D. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. Jenkins, B. A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid c and heptadecanoic Acid c in health and disease.

Molecules 20, — Jésus, P. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.

Jiang, F. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. Jin, S.

Lipid raft redox signaling: molecular mechanisms in health and disease. Redox Signal. Kamp, F. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. U S A 89, — Kampf, J. Different mechanisms of free fatty acid flip-flop and dissociation revealed by temperature and molecular species dependence of transport across lipid vesicles.

Kandutsch, A. Preputial gland tumor sterols. The identification of 4 alpha-methyl-Delta 8-cholesten-3 beta-ol. Kanno, K. Kano, M. Endocannabinoid-mediated control of synaptic transmission.

Karupaiah, T. Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications.

Fatty acid pathwayys is Oxifation multistep process Energize your workouts which fatty patwhays are broken down by various tissues Fa produce oxiation. Fatty acids oxidstion enter a cell via fatty acid protein transporters on the pathwayd surface [1]. Once Body composition monitoring the cell, a CoA group is Fat oxidation pathways to the fatty acid by fatty acyl-CoA synthase FACSforming long-chain acyl-CoA. Carnitine palmitoyltransferase 1 CPT1 conversion of the long-chain acyl-CoA to long-chain acylcarnitine allows the fatty acid moiety to be transported across the inner mitochondrial membrane via carnitine translocase CATwhich exchanges long-chain acylcarnitines for carnitine. An inner mitochondrial membrane CPT2 then converts the long-chain acylcarnitine back to long-chain acyl-CoA. The long-chain acyl-CoA enters the fatty acid β-oxidation pathway, which results in the production of one acetyl-CoA from each cycle of fatty acid β-oxidation.

Author: Tojahn

3 thoughts on “Fat oxidation pathways

  1. Jetzt kann ich an der Diskussion nicht teilnehmen - es gibt keine freie Zeit. Aber bald werde ich unbedingt schreiben dass ich denke.

Leave a comment

Yours email will be published. Important fields a marked *

Design by